Check J H, Lurie D, Peymer M, Katsoff D, Long R
The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, USA.
Arch Androl. 2000 May-Jun;44(3):193-6.
The efficacy of intrauterine insemination (IUI) for male or cervical factor by age of female partner was determined in a retrospective analysis. Patients who underwent IUI therapy for cervical and/or male factor (n = 281) were classified by age at first IUI cycle: <40 years (n = 232), > or =40 years (n = 49). The indication for IUI was cervical factor if a postcoital test failed to show sperm with good forward progression at time of mature follicle; male factor was diagnosed if the semen analysis demonstrated either low count, low motility, antisperm antibodies, or subnormal hypoosmotic swelling test. Intrauterine insemination was performed in either natural cycles or following ovarian stimulation for the treatment of anovulation or follicular maturation defects. Cumulative probability of ongoing pregnancy (viable at end of first trimester) following 3 cycles of IUI was evaluated. Cumulative probability of ongoing pregnancy following 3 cycles of IUI was 28.2% for the younger group and 0.0% for the older group. The age groups did not differ in terms of infertility history, use of ovarian stimulation, or baseline semen parameters. Thus, the treatment of male and/or cervical factor by IUI is ineffective for women > or =40 years.
通过一项回顾性分析确定了宫内人工授精(IUI)针对男性因素或宫颈因素且根据女性伴侣年龄的疗效。因宫颈和/或男性因素接受IUI治疗的患者(n = 281)根据首次IUI周期时的年龄进行分类:<40岁(n = 232),≥40岁(n = 49)。如果性交后试验在成熟卵泡期未能显示出具有良好前向运动能力的精子,则IUI的指征为宫颈因素;如果精液分析显示精子数量少、活力低、存在抗精子抗体或低渗肿胀试验异常,则诊断为男性因素。宫内人工授精在自然周期或卵巢刺激后进行,以治疗无排卵或卵泡成熟缺陷。评估了IUI三个周期后持续妊娠(孕早期末存活)的累积概率。IUI三个周期后,较年轻组的持续妊娠累积概率为28.2%,较年长组为0.0%。两组在不孕史、卵巢刺激的使用或基线精液参数方面无差异。因此,对于≥40岁的女性,通过IUI治疗男性和/或宫颈因素无效。